|"COVAXIN" Approved For Human Trials!|
The outbreak of the COVID-19 has brought the world to a halt. A worldwide lockdown has been imposed and people are being quarantined by the dozen. As the infections rise and death rate surges, officials are struggling hard to find a cure.
Many major players in the pharmaceutical sector are in the race for making the first COVID-19 vaccine. However, it seems that India might be leading this race. Developed by Bharat Biotech, India's First COVID-19 Vaccine "COVAXIN" Approved For Human Trials! The potential COVID-19 vaccnine is developed by Bharat Biotech in collaboration with the
Indian Council Of Medical Research (ICMR) and the National Institute Of Virology (NIV).
Bharat Biotech is a pharmaceutical company based out of Hyderabad, Andhra Pradesh. COVAXIN might be India's First COVID-19 Vaccine Approved For Human Trials. The
Drug Controller General Of India (DCGI) has given their approval to Bharat Biotech to conduct Phase 1 and Phase 2 human clinical trials of the potential COVID-19 vaccine COVAXIN.